Case Studies/Research/CELLULAREVOLUTION LIMITED
Creditors' voluntary liquidation

CELLULAREVOLUTION LIMITED

CELLULAREVOLUTION LIMITED is tracked from The Gazette and Companies House public record. Creditors' voluntary liquidation proceedings were first recorded on 17 July 2026.

Key facts
Company no.11732114
SectorResearch
Incorporated18 Dec 2018
Reg. officeLeeds LS1
Appointed17 Jul 2026
The timeline · incorporation → liquidation
18 Dec 2018
Incorporated
Registered as 11732114. Research.
18 Nov 2020
First accounts filed
accounts-with-accounts-type-micro-entity
23 Jun 2022
Board changes begin
First of the director resignations before failure.
8 Apr 2025
Latest accounts filed
accounts-with-accounts-type-total-exemption-full
18 Sep 2025
Statement of affairs
Administrators' statement of the company's affairs.
9 Oct 2025
Administrator's proposals
Administrators' statement of proposals to creditors.
4 Nov 2025
Result of creditors' meeting
Outcome of the meeting of creditors.
12 Mar 2026
Progress report
Administrators' progress report to creditors.
9 Jul 2026
Moved to liquidation
Move from administration to creditors' voluntary liquidation.
17 Jul 2026
Liquidator appointed
Creditors' voluntary liquidation.
17 Jul 2026
Gazette notice published
Notice 5176329 in The Gazette.

What the data was telling us

Readings from The Gazette and Companies House, in the firm's final two years.

Insolvency statusCVL
StatusCreditors' voluntary liquidation
Gazette refNotice 5176329
EditionThe Gazette
Appointed byMembers & creditors
UnderInsolvency Act 1986, s.100 & s.109
Filing trajectoryLate filing
Incorporated18 Dec 2018
Last accounts8 Apr 2025
Confirmation stmtOverdue
Account typeFull
Director stabilityBoard churn
Appointments7 since 2018
Resignations0 in final 12 mths
Active directors6
Avg tenure4.4 yrs
Director track recordRepeat insolvency
Other appointments7 other companies
Prior insolvencies1 dissolved or insolvent
DisqualificationsNone found
The full forensic report

Every charge, every filing, every appointment, in one dossier.

Director histories across related entities, the full debenture instrument, creditor estimates, and the practitioner's record on comparable cases for CELLULAREVOLUTION LIMITED.